IBDEI04G ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5672,1,4,0)
 ;;=4^370.40
 ;;^UTILITY(U,$J,358.3,5672,2)
 ;;=^66777
 ;;^UTILITY(U,$J,358.3,5673,0)
 ;;=694.5^^36^393^95
 ;;^UTILITY(U,$J,358.3,5673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5673,1,3,0)
 ;;=3^Pemphigoid
 ;;^UTILITY(U,$J,358.3,5673,1,4,0)
 ;;=4^694.5
 ;;^UTILITY(U,$J,358.3,5673,2)
 ;;=Pemphigoid^91108
 ;;^UTILITY(U,$J,358.3,5674,0)
 ;;=364.10^^36^393^54
 ;;^UTILITY(U,$J,358.3,5674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5674,1,3,0)
 ;;=3^Iridocyclitis, Chronic
 ;;^UTILITY(U,$J,358.3,5674,1,4,0)
 ;;=4^364.10
 ;;^UTILITY(U,$J,358.3,5674,2)
 ;;=Iridocyclitis, Chronic^24398
 ;;^UTILITY(U,$J,358.3,5675,0)
 ;;=054.44^^36^393^55
 ;;^UTILITY(U,$J,358.3,5675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5675,1,3,0)
 ;;=3^Iridocyclitis, H Simplex
 ;;^UTILITY(U,$J,358.3,5675,1,4,0)
 ;;=4^054.44
 ;;^UTILITY(U,$J,358.3,5675,2)
 ;;=Iridocyclitis, H Simplex^266565
 ;;^UTILITY(U,$J,358.3,5676,0)
 ;;=053.22^^36^393^56
 ;;^UTILITY(U,$J,358.3,5676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5676,1,3,0)
 ;;=3^Iridocyclitis, H Zoster
 ;;^UTILITY(U,$J,358.3,5676,1,4,0)
 ;;=4^053.22
 ;;^UTILITY(U,$J,358.3,5676,2)
 ;;=Iridocyclitis, H Zoster^266554
 ;;^UTILITY(U,$J,358.3,5677,0)
 ;;=364.42^^36^393^111
 ;;^UTILITY(U,$J,358.3,5677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5677,1,3,0)
 ;;=3^Rubeosis Iridis
 ;;^UTILITY(U,$J,358.3,5677,1,4,0)
 ;;=4^364.42
 ;;^UTILITY(U,$J,358.3,5677,2)
 ;;=Rubeosis Iridis^268716
 ;;^UTILITY(U,$J,358.3,5678,0)
 ;;=364.59^^36^393^59
 ;;^UTILITY(U,$J,358.3,5678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5678,1,3,0)
 ;;=3^Iris Atrophy,Other
 ;;^UTILITY(U,$J,358.3,5678,1,4,0)
 ;;=4^364.59
 ;;^UTILITY(U,$J,358.3,5678,2)
 ;;=Iris Atrophy^268731
 ;;^UTILITY(U,$J,358.3,5679,0)
 ;;=224.0^^36^393^11
 ;;^UTILITY(U,$J,358.3,5679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5679,1,3,0)
 ;;=3^Benign Neopl of Iris
 ;;^UTILITY(U,$J,358.3,5679,1,4,0)
 ;;=4^224.0
 ;;^UTILITY(U,$J,358.3,5679,2)
 ;;=^267670
 ;;^UTILITY(U,$J,358.3,5680,0)
 ;;=364.72^^36^393^6
 ;;^UTILITY(U,$J,358.3,5680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5680,1,3,0)
 ;;=3^Anterior Synechiae
 ;;^UTILITY(U,$J,358.3,5680,1,4,0)
 ;;=4^364.72
 ;;^UTILITY(U,$J,358.3,5680,2)
 ;;=Anterior Synechiae^265517
 ;;^UTILITY(U,$J,358.3,5681,0)
 ;;=364.71^^36^393^102
 ;;^UTILITY(U,$J,358.3,5681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5681,1,3,0)
 ;;=3^Posterior Synechiae
 ;;^UTILITY(U,$J,358.3,5681,1,4,0)
 ;;=4^364.71
 ;;^UTILITY(U,$J,358.3,5681,2)
 ;;=Posterior Synechiae^265519
 ;;^UTILITY(U,$J,358.3,5682,0)
 ;;=364.00^^36^393^57
 ;;^UTILITY(U,$J,358.3,5682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5682,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
 ;;^UTILITY(U,$J,358.3,5682,1,4,0)
 ;;=4^364.00
 ;;^UTILITY(U,$J,358.3,5682,2)
 ;;=Iridocyclitis, Acute^268703
 ;;^UTILITY(U,$J,358.3,5683,0)
 ;;=379.40^^36^393^106
 ;;^UTILITY(U,$J,358.3,5683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5683,1,3,0)
 ;;=3^Pupil, Abnormal function
 ;;^UTILITY(U,$J,358.3,5683,1,4,0)
 ;;=4^379.40
 ;;^UTILITY(U,$J,358.3,5683,2)
 ;;=Pupil, Abnormal function^101288
 ;;^UTILITY(U,$J,358.3,5684,0)
 ;;=190.0^^36^393^84
 ;;^UTILITY(U,$J,358.3,5684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5684,1,3,0)
 ;;=3^Malig Neopl of Eyeball,Iris
 ;;^UTILITY(U,$J,358.3,5684,1,4,0)
 ;;=4^190.0
 ;;^UTILITY(U,$J,358.3,5684,2)
 ;;=Malig Neopl of Iris^267271
 ;;^UTILITY(U,$J,358.3,5685,0)
 ;;=190.3^^36^393^83
 ;;^UTILITY(U,$J,358.3,5685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5685,1,3,0)
 ;;=3^Malig Neopl Conjunctiva
 ;;^UTILITY(U,$J,358.3,5685,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,5685,2)
 ;;=Malig Neopl Conjunctiva^267274
 ;;^UTILITY(U,$J,358.3,5686,0)
 ;;=364.41^^36^393^50
 ;;^UTILITY(U,$J,358.3,5686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5686,1,3,0)
 ;;=3^Hyphema
 ;;^UTILITY(U,$J,358.3,5686,1,4,0)
 ;;=4^364.41
 ;;^UTILITY(U,$J,358.3,5686,2)
 ;;=Hyphema^60498
 ;;^UTILITY(U,$J,358.3,5687,0)
 ;;=364.05^^36^393^51
 ;;^UTILITY(U,$J,358.3,5687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5687,1,3,0)
 ;;=3^Hypopyon
 ;;^UTILITY(U,$J,358.3,5687,1,4,0)
 ;;=4^364.05
 ;;^UTILITY(U,$J,358.3,5687,2)
 ;;=Hypopion^60720
 ;;^UTILITY(U,$J,358.3,5688,0)
 ;;=365.02^^36^393^4
 ;;^UTILITY(U,$J,358.3,5688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5688,1,3,0)
 ;;=3^Angle, Narrow
 ;;^UTILITY(U,$J,358.3,5688,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,5688,2)
 ;;=Angle, Narrow^268748
 ;;^UTILITY(U,$J,358.3,5689,0)
 ;;=372.63^^36^393^117
 ;;^UTILITY(U,$J,358.3,5689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5689,1,3,0)
 ;;=3^Symblepharon
 ;;^UTILITY(U,$J,358.3,5689,1,4,0)
 ;;=4^372.63
 ;;^UTILITY(U,$J,358.3,5689,2)
 ;;=Symblepharon^265885
 ;;^UTILITY(U,$J,358.3,5690,0)
 ;;=372.75^^36^393^27
 ;;^UTILITY(U,$J,358.3,5690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5690,1,3,0)
 ;;=3^Cysts, Conjunctival
 ;;^UTILITY(U,$J,358.3,5690,1,4,0)
 ;;=4^372.75
 ;;^UTILITY(U,$J,358.3,5690,2)
 ;;=Cysts, Conjunctival^269049
 ;;^UTILITY(U,$J,358.3,5691,0)
 ;;=364.81^^36^393^43
 ;;^UTILITY(U,$J,358.3,5691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5691,1,3,0)
 ;;=3^Floppy Iris Syndrome
 ;;^UTILITY(U,$J,358.3,5691,1,4,0)
 ;;=4^364.81
 ;;^UTILITY(U,$J,358.3,5691,2)
 ;;=^335254
 ;;^UTILITY(U,$J,358.3,5692,0)
 ;;=006.9^^36^393^2
 ;;^UTILITY(U,$J,358.3,5692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5692,1,3,0)
 ;;=3^Amebiasis
 ;;^UTILITY(U,$J,358.3,5692,1,4,0)
 ;;=4^006.9
 ;;^UTILITY(U,$J,358.3,5692,2)
 ;;=^5818
 ;;^UTILITY(U,$J,358.3,5693,0)
 ;;=190.8^^36^393^60
 ;;^UTILITY(U,$J,358.3,5693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5693,1,3,0)
 ;;=3^Iris Melanoma,Contiguous Site
 ;;^UTILITY(U,$J,358.3,5693,1,4,0)
 ;;=4^190.8
 ;;^UTILITY(U,$J,358.3,5693,2)
 ;;=^267278
 ;;^UTILITY(U,$J,358.3,5694,0)
 ;;=224.1^^36^393^93
 ;;^UTILITY(U,$J,358.3,5694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5694,1,3,0)
 ;;=3^Orbit Neoplasm,Benign
 ;;^UTILITY(U,$J,358.3,5694,1,4,0)
 ;;=4^224.1
 ;;^UTILITY(U,$J,358.3,5694,2)
 ;;=^267671
 ;;^UTILITY(U,$J,358.3,5695,0)
 ;;=360.33^^36^393^52
 ;;^UTILITY(U,$J,358.3,5695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5695,1,3,0)
 ;;=3^Hypotony,Assoc w/ Ocular D/O
 ;;^UTILITY(U,$J,358.3,5695,1,4,0)
 ;;=4^360.33
 ;;^UTILITY(U,$J,358.3,5695,2)
 ;;=^268560
 ;;^UTILITY(U,$J,358.3,5696,0)
 ;;=224.8^^36^393^86
 ;;^UTILITY(U,$J,358.3,5696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5696,1,3,0)
 ;;=3^Neopl Eye Bgn,Oth Iris Nevus
 ;;^UTILITY(U,$J,358.3,5696,1,4,0)
 ;;=4^224.8
 ;;^UTILITY(U,$J,358.3,5696,2)
 ;;=^267678
 ;;^UTILITY(U,$J,358.3,5697,0)
 ;;=364.01^^36^393^103
 ;;^UTILITY(U,$J,358.3,5697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5697,1,3,0)
 ;;=3^Prim Iridocyclitis
 ;;^UTILITY(U,$J,358.3,5697,1,4,0)
 ;;=4^364.01
 ;;^UTILITY(U,$J,358.3,5697,2)
 ;;=^268704
 ;;^UTILITY(U,$J,358.3,5698,0)
 ;;=364.04^^36^393^53
 ;;^UTILITY(U,$J,358.3,5698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5698,1,3,0)
 ;;=3^Iridociclyties 2ary,Non Infectious
 ;;^UTILITY(U,$J,358.3,5698,1,4,0)
 ;;=4^364.04
 ;;^UTILITY(U,$J,358.3,5698,2)
 ;;=^268710
 ;;^UTILITY(U,$J,358.3,5699,0)
 ;;=364.21^^36^393^46
 ;;^UTILITY(U,$J,358.3,5699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5699,1,3,0)
 ;;=3^Fuch's Hetero Cyclitis
 ;;^UTILITY(U,$J,358.3,5699,1,4,0)
 ;;=4^364.21
 ;;^UTILITY(U,$J,358.3,5699,2)
 ;;=^48468
 ;;^UTILITY(U,$J,358.3,5700,0)
 ;;=364.23^^36^393^81
 ;;^UTILITY(U,$J,358.3,5700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5700,1,3,0)
 ;;=3^Lens-Induced Iridocyclitis
 ;;^UTILITY(U,$J,358.3,5700,1,4,0)
 ;;=4^364.23
 ;;^UTILITY(U,$J,358.3,5700,2)
 ;;=^268713
 ;;^UTILITY(U,$J,358.3,5701,0)
 ;;=364.51^^36^393^8
 ;;^UTILITY(U,$J,358.3,5701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5701,1,3,0)
 ;;=3^Atrophy Iris Essential/Progressive
 ;;^UTILITY(U,$J,358.3,5701,1,4,0)
 ;;=4^364.51
 ;;^UTILITY(U,$J,358.3,5701,2)
 ;;=^268718
 ;;^UTILITY(U,$J,358.3,5702,0)
 ;;=364.53^^36^393^100
 ;;^UTILITY(U,$J,358.3,5702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5702,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,5702,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,5702,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,5703,0)
 ;;=364.57^^36^393^33
 ;;^UTILITY(U,$J,358.3,5703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5703,1,3,0)
 ;;=3^Degen Ciliary Body Changes
 ;;^UTILITY(U,$J,358.3,5703,1,4,0)
 ;;=4^364.57
 ;;^UTILITY(U,$J,358.3,5703,2)
 ;;=^268728
 ;;^UTILITY(U,$J,358.3,5704,0)
 ;;=364.60^^36^393^26
 ;;^UTILITY(U,$J,358.3,5704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5704,1,3,0)
 ;;=3^Cyst,Idiopathic
 ;;^UTILITY(U,$J,358.3,5704,1,4,0)
 ;;=4^364.60
 ;;^UTILITY(U,$J,358.3,5704,2)
 ;;=^268733
 ;;^UTILITY(U,$J,358.3,5705,0)
 ;;=364.73^^36^393^97
 ;;^UTILITY(U,$J,358.3,5705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5705,1,3,0)
 ;;=3^Peripheral Ant Synechiae
 ;;^UTILITY(U,$J,358.3,5705,1,4,0)
 ;;=4^364.73
 ;;^UTILITY(U,$J,358.3,5705,2)
 ;;=^268740
 ;;^UTILITY(U,$J,358.3,5706,0)
 ;;=364.75^^36^393^107
 ;;^UTILITY(U,$J,358.3,5706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5706,1,3,0)
 ;;=3^Pupillary Abnormalities
 ;;^UTILITY(U,$J,358.3,5706,1,4,0)
 ;;=4^364.75
 ;;^UTILITY(U,$J,358.3,5706,2)
 ;;=^268742
 ;;^UTILITY(U,$J,358.3,5707,0)
 ;;=364.76^^36^393^58
 ;;^UTILITY(U,$J,358.3,5707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5707,1,3,0)
 ;;=3^Iridodialysis
 ;;^UTILITY(U,$J,358.3,5707,1,4,0)
 ;;=4^364.76
 ;;^UTILITY(U,$J,358.3,5707,2)
 ;;=^265499
 ;;^UTILITY(U,$J,358.3,5708,0)
 ;;=364.77^^36^393^3
 ;;^UTILITY(U,$J,358.3,5708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5708,1,3,0)
 ;;=3^Angle Recession w/o Glauc
 ;;^UTILITY(U,$J,358.3,5708,1,4,0)
 ;;=4^364.77
 ;;^UTILITY(U,$J,358.3,5708,2)
 ;;=^268743
 ;;^UTILITY(U,$J,358.3,5709,0)
 ;;=364.89^^36^393^62
 ;;^UTILITY(U,$J,358.3,5709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5709,1,3,0)
 ;;=3^Iris/Ciliary D/O,Other
